Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Comedy and tragedy masks on red curtain background
Biotech

MapLight shares sink on mixed ph. 2 schizophrenia readout

The biotech's schizophrenia candidate hit its primary endpoint when given twice a day, but not when administered as a daily dose.
Darren Incorvaia Jul 27, 2026 11:37am
bedroom sleep

Apnimed aspires for up to $160M IPO as sleep apnea launch nears

Jul 27, 2026 11:30am
Biotech value creation at an inflection point

Biotech value creation at an inflection point

Brought to you by Lumanity
scrabble tiles spelling out psoriasis

InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test

Jul 27, 2026 10:08am
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
contract

Gossamer and Chiesi pull the plug on PAH drug collaboration

Jul 27, 2026 10:03am